Capital Fund Management (CFM)
FLGT icon

Capital Fund Management (CFM)’s Fulgent Genetics FLGT Stock Holding History

Capital Fund Management (CFM)’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-31,170
Closed -$335K – 1213
2020
Q1 		$335K Buy
31,170
+20,689
+197% +$288K 0.01% 1184
2019
Q4 		$135K Buy
+10,481
New +$125K ﹤0.01% 1769

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Fund Management (CFM)'s FLGT Position: Q2 2020 in Review

Capital Fund Management (CFM) sold out of Fulgent Genetics (FLGT) in Q2 2020, closing a stake of 31,170 shares — an estimated $335K sold.

Capital Fund Management (CFM) first reported a position in FLGT in Q4 2019 and held it in 2 quarters. The position peaked at $335K in Q1 2020. 86 funds tracked by Wall St. Rank hold FLGT as of Q2 2020.

  • Capital Fund Management (CFM) reported no remaining Fulgent Genetics position as of Q2 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 31,170 Fulgent Genetics shares in Q2 2020, an estimated $335K.
  • Capital Fund Management (CFM) first reported a position in Fulgent Genetics in Q4 2019 and held it in 2 quarters.
  • Capital Fund Management (CFM)'s Fulgent Genetics position peaked at $335K in Q1 2020.
  • 86 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2020, filed 13 Aug 2020.